Solid Dosage Pharmaceutical Excipients - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB512240948

Publication Date:

December 12, 2024

Pages:

122

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Specialty Chemicals [2]

Manufacturing (Chemicals) [3]

Chemicals [4]

Description:

Solid dosage pharmaceutical excipients are inactive substances or ingredients used alongside active pharmaceutical ingredients (APIs) in the formulation of solid dosage forms such as tablets, capsules, powders, or granules. These excipients play a crucial role in the manufacturing process and the overall performance of the dosage form. While APIs are responsible for the therapeutic effect of a medication, excipients serve various functions to facilitate drug delivery, improve stability, enhance bioavailability, and provide desirable physical characteristics.
The global market for Solid Dosage Pharmaceutical Excipients was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The solid dose pharmaceutical excipients market is witnessing steady growth driven by factors such as rising prevalence of chronic diseases, increasing demand for generic drugs, advancements in drug delivery technologies, and growing global pharmaceutical industry. The market is expected to continue its upward trend in the coming years. In terms of regions, North America is expected to remain the largest market for solid dosage pharmaceutical excipients during the forecast period, followed by Europe and Asia Pacific.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Solid Dosage Pharmaceutical Excipients, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Solid Dosage Pharmaceutical Excipients by region & country, by Type, and by Application.
The Solid Dosage Pharmaceutical Excipients market size, estimations, and forecasts are provided in terms of sales volume (Kiloton) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Solid Dosage Pharmaceutical Excipients.
Market Segmentation
By Company
Colorcon
Evonik Industries
DuPont
JRS Pharma
Lubrizol
BASF
Roquette
Croda International
ABITEC
Shin-Etsu Chemical
Associated British Foods
Hunan ER-KANG
Anhui Sunhere
Segment by Type:
Cellulose and Derivatives
Starch and Derivatives
Others
Segment by Application
Binder
Disintegrant
Glidant
Diluent
Dispersing Agent
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Solid Dosage Pharmaceutical Excipients manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Solid Dosage Pharmaceutical Excipients in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Solid Dosage Pharmaceutical Excipients in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Solid Dosage Pharmaceutical Excipients Product Introduction
1.2 Global Solid Dosage Pharmaceutical Excipients Market Size Forecast
1.2.1 Global Solid Dosage Pharmaceutical Excipients Sales Value (2019-2030)
1.2.2 Global Solid Dosage Pharmaceutical Excipients Sales Volume (2019-2030)
1.2.3 Global Solid Dosage Pharmaceutical Excipients Sales Price (2019-2030)
1.3 Solid Dosage Pharmaceutical Excipients Market Trends & Drivers
1.3.1 Solid Dosage Pharmaceutical Excipients Industry Trends
1.3.2 Solid Dosage Pharmaceutical Excipients Market Drivers & Opportunity
1.3.3 Solid Dosage Pharmaceutical Excipients Market Challenges
1.3.4 Solid Dosage Pharmaceutical Excipients Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Solid Dosage Pharmaceutical Excipients Players Revenue Ranking (2023)
2.2 Global Solid Dosage Pharmaceutical Excipients Revenue by Company (2019-2024)
2.3 Global Solid Dosage Pharmaceutical Excipients Players Sales Volume Ranking (2023)
2.4 Global Solid Dosage Pharmaceutical Excipients Sales Volume by Company Players (2019-2024)
2.5 Global Solid Dosage Pharmaceutical Excipients Average Price by Company (2019-2024)
2.6 Key Manufacturers Solid Dosage Pharmaceutical Excipients Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Solid Dosage Pharmaceutical Excipients Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Solid Dosage Pharmaceutical Excipients
2.9 Solid Dosage Pharmaceutical Excipients Market Competitive Analysis
2.9.1 Solid Dosage Pharmaceutical Excipients Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Solid Dosage Pharmaceutical Excipients Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solid Dosage Pharmaceutical Excipients as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Cellulose and Derivatives
3.1.2 Starch and Derivatives
3.1.3 Others
3.2 Global Solid Dosage Pharmaceutical Excipients Sales Value by Type
3.2.1 Global Solid Dosage Pharmaceutical Excipients Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Solid Dosage Pharmaceutical Excipients Sales Value, by Type (2019-2030)
3.2.3 Global Solid Dosage Pharmaceutical Excipients Sales Value, by Type (%) (2019-2030)
3.3 Global Solid Dosage Pharmaceutical Excipients Sales Volume by Type
3.3.1 Global Solid Dosage Pharmaceutical Excipients Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Solid Dosage Pharmaceutical Excipients Sales Volume, by Type (2019-2030)
3.3.3 Global Solid Dosage Pharmaceutical Excipients Sales Volume, by Type (%) (2019-2030)
3.4 Global Solid Dosage Pharmaceutical Excipients Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Binder
4.1.2 Disintegrant
4.1.3 Glidant
4.1.4 Diluent
4.1.5 Dispersing Agent
4.1.6 Others
4.2 Global Solid Dosage Pharmaceutical Excipients Sales Value by Application
4.2.1 Global Solid Dosage Pharmaceutical Excipients Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Solid Dosage Pharmaceutical Excipients Sales Value, by Application (2019-2030)
4.2.3 Global Solid Dosage Pharmaceutical Excipients Sales Value, by Application (%) (2019-2030)
4.3 Global Solid Dosage Pharmaceutical Excipients Sales Volume by Application
4.3.1 Global Solid Dosage Pharmaceutical Excipients Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Solid Dosage Pharmaceutical Excipients Sales Volume, by Application (2019-2030)
4.3.3 Global Solid Dosage Pharmaceutical Excipients Sales Volume, by Application (%) (2019-2030)
4.4 Global Solid Dosage Pharmaceutical Excipients Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Solid Dosage Pharmaceutical Excipients Sales Value by Region
5.1.1 Global Solid Dosage Pharmaceutical Excipients Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Solid Dosage Pharmaceutical Excipients Sales Value by Region (2019-2024)
5.1.3 Global Solid Dosage Pharmaceutical Excipients Sales Value by Region (2025-2030)
5.1.4 Global Solid Dosage Pharmaceutical Excipients Sales Value by Region (%), (2019-2030)
5.2 Global Solid Dosage Pharmaceutical Excipients Sales Volume by Region
5.2.1 Global Solid Dosage Pharmaceutical Excipients Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Solid Dosage Pharmaceutical Excipients Sales Volume by Region (2019-2024)
5.2.3 Global Solid Dosage Pharmaceutical Excipients Sales Volume by Region (2025-2030)
5.2.4 Global Solid Dosage Pharmaceutical Excipients Sales Volume by Region (%), (2019-2030)
5.3 Global Solid Dosage Pharmaceutical Excipients Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Solid Dosage Pharmaceutical Excipients Sales Value, 2019-2030
5.4.2 North America Solid Dosage Pharmaceutical Excipients Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Solid Dosage Pharmaceutical Excipients Sales Value, 2019-2030
5.5.2 Europe Solid Dosage Pharmaceutical Excipients Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Solid Dosage Pharmaceutical Excipients Sales Value, 2019-2030
5.6.2 Asia Pacific Solid Dosage Pharmaceutical Excipients Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Solid Dosage Pharmaceutical Excipients Sales Value, 2019-2030
5.7.2 South America Solid Dosage Pharmaceutical Excipients Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Solid Dosage Pharmaceutical Excipients Sales Value, 2019-2030
5.8.2 Middle East & Africa Solid Dosage Pharmaceutical Excipients Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Solid Dosage Pharmaceutical Excipients Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Solid Dosage Pharmaceutical Excipients Sales Value
6.2.1 Key Countries/Regions Solid Dosage Pharmaceutical Excipients Sales Value, 2019-2030
6.2.2 Key Countries/Regions Solid Dosage Pharmaceutical Excipients Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Solid Dosage Pharmaceutical Excipients Sales Value, 2019-2030
6.3.2 United States Solid Dosage Pharmaceutical Excipients Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Solid Dosage Pharmaceutical Excipients Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Solid Dosage Pharmaceutical Excipients Sales Value, 2019-2030
6.4.2 Europe Solid Dosage Pharmaceutical Excipients Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Solid Dosage Pharmaceutical Excipients Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Solid Dosage Pharmaceutical Excipients Sales Value, 2019-2030
6.5.2 China Solid Dosage Pharmaceutical Excipients Sales Value by Type (%), 2023 VS 2030
6.5.3 China Solid Dosage Pharmaceutical Excipients Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Solid Dosage Pharmaceutical Excipients Sales Value, 2019-2030
6.6.2 Japan Solid Dosage Pharmaceutical Excipients Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Solid Dosage Pharmaceutical Excipients Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Solid Dosage Pharmaceutical Excipients Sales Value, 2019-2030
6.7.2 South Korea Solid Dosage Pharmaceutical Excipients Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Solid Dosage Pharmaceutical Excipients Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Solid Dosage Pharmaceutical Excipients Sales Value, 2019-2030
6.8.2 Southeast Asia Solid Dosage Pharmaceutical Excipients Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Solid Dosage Pharmaceutical Excipients Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Solid Dosage Pharmaceutical Excipients Sales Value, 2019-2030
6.9.2 India Solid Dosage Pharmaceutical Excipients Sales Value by Type (%), 2023 VS 2030
6.9.3 India Solid Dosage Pharmaceutical Excipients Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Colorcon
7.1.1 Colorcon Company Information
7.1.2 Colorcon Introduction and Business Overview
7.1.3 Colorcon Solid Dosage Pharmaceutical Excipients Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Colorcon Solid Dosage Pharmaceutical Excipients Product Offerings
7.1.5 Colorcon Recent Development
7.2 Evonik Industries
7.2.1 Evonik Industries Company Information
7.2.2 Evonik Industries Introduction and Business Overview
7.2.3 Evonik Industries Solid Dosage Pharmaceutical Excipients Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Evonik Industries Solid Dosage Pharmaceutical Excipients Product Offerings
7.2.5 Evonik Industries Recent Development
7.3 DuPont
7.3.1 DuPont Company Information
7.3.2 DuPont Introduction and Business Overview
7.3.3 DuPont Solid Dosage Pharmaceutical Excipients Sales, Revenue and Gross Margin (2019-2024)
7.3.4 DuPont Solid Dosage Pharmaceutical Excipients Product Offerings
7.3.5 DuPont Recent Development
7.4 JRS Pharma
7.4.1 JRS Pharma Company Information
7.4.2 JRS Pharma Introduction and Business Overview
7.4.3 JRS Pharma Solid Dosage Pharmaceutical Excipients Sales, Revenue and Gross Margin (2019-2024)
7.4.4 JRS Pharma Solid Dosage Pharmaceutical Excipients Product Offerings
7.4.5 JRS Pharma Recent Development
7.5 Lubrizol
7.5.1 Lubrizol Company Information
7.5.2 Lubrizol Introduction and Business Overview
7.5.3 Lubrizol Solid Dosage Pharmaceutical Excipients Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Lubrizol Solid Dosage Pharmaceutical Excipients Product Offerings
7.5.5 Lubrizol Recent Development
7.6 BASF
7.6.1 BASF Company Information
7.6.2 BASF Introduction and Business Overview
7.6.3 BASF Solid Dosage Pharmaceutical Excipients Sales, Revenue and Gross Margin (2019-2024)
7.6.4 BASF Solid Dosage Pharmaceutical Excipients Product Offerings
7.6.5 BASF Recent Development
7.7 Roquette
7.7.1 Roquette Company Information
7.7.2 Roquette Introduction and Business Overview
7.7.3 Roquette Solid Dosage Pharmaceutical Excipients Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Roquette Solid Dosage Pharmaceutical Excipients Product Offerings
7.7.5 Roquette Recent Development
7.8 Croda International
7.8.1 Croda International Company Information
7.8.2 Croda International Introduction and Business Overview
7.8.3 Croda International Solid Dosage Pharmaceutical Excipients Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Croda International Solid Dosage Pharmaceutical Excipients Product Offerings
7.8.5 Croda International Recent Development
7.9 ABITEC
7.9.1 ABITEC Company Information
7.9.2 ABITEC Introduction and Business Overview
7.9.3 ABITEC Solid Dosage Pharmaceutical Excipients Sales, Revenue and Gross Margin (2019-2024)
7.9.4 ABITEC Solid Dosage Pharmaceutical Excipients Product Offerings
7.9.5 ABITEC Recent Development
7.10 Shin-Etsu Chemical
7.10.1 Shin-Etsu Chemical Company Information
7.10.2 Shin-Etsu Chemical Introduction and Business Overview
7.10.3 Shin-Etsu Chemical Solid Dosage Pharmaceutical Excipients Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Shin-Etsu Chemical Solid Dosage Pharmaceutical Excipients Product Offerings
7.10.5 Shin-Etsu Chemical Recent Development
7.11 Associated British Foods
7.11.1 Associated British Foods Company Information
7.11.2 Associated British Foods Introduction and Business Overview
7.11.3 Associated British Foods Solid Dosage Pharmaceutical Excipients Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Associated British Foods Solid Dosage Pharmaceutical Excipients Product Offerings
7.11.5 Associated British Foods Recent Development
7.12 Hunan ER-KANG
7.12.1 Hunan ER-KANG Company Information
7.12.2 Hunan ER-KANG Introduction and Business Overview
7.12.3 Hunan ER-KANG Solid Dosage Pharmaceutical Excipients Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Hunan ER-KANG Solid Dosage Pharmaceutical Excipients Product Offerings
7.12.5 Hunan ER-KANG Recent Development
7.13 Anhui Sunhere
7.13.1 Anhui Sunhere Company Information
7.13.2 Anhui Sunhere Introduction and Business Overview
7.13.3 Anhui Sunhere Solid Dosage Pharmaceutical Excipients Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Anhui Sunhere Solid Dosage Pharmaceutical Excipients Product Offerings
7.13.5 Anhui Sunhere Recent Development
8 Industry Chain Analysis
8.1 Solid Dosage Pharmaceutical Excipients Industrial Chain
8.2 Solid Dosage Pharmaceutical Excipients Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Solid Dosage Pharmaceutical Excipients Sales Model
8.5.2 Sales Channel
8.5.3 Solid Dosage Pharmaceutical Excipients Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Colorcon
Evonik Industries
DuPont
JRS Pharma
Lubrizol
BASF
Roquette
Croda International
ABITEC
Shin-Etsu Chemical
Associated British Foods
Hunan ER-KANG
Anhui Sunhere

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂